03.09.2026 Lenacapavir HIV prevention faces SA supply constraints Lenacapavir HIV prevention could accelerate South Africa’s epidemic control, but severe supply constraints are limiting the rollout. This article is for Health Matters subscribers Subscribers read every article in full, receive the daily briefing and have access to the complete archive. SubscribeLog in Department of Health, Gilead, Global Fund, HIV Prevention, lenacapavir, PrEP